S. Fazel and J. Baillargeon, The health of prisoners, The Lancet, vol.377, issue.9769, 2010.
DOI : 10.1016/S0140-6736(10)61053-7

K. Dolan, B. Kite, E. Black, C. Aceijas, and G. Stimson, HIV in prison in low-income and middle-income countries, The Lancet Infectious Diseases, vol.7, issue.1, pp.32-41, 2007.
DOI : 10.1016/S1473-3099(06)70685-5

R. Jurgens, A. Ball, and A. Verster, Interventions to reduce HIV transmission related to injecting drug use in prison, The Lancet Infectious Diseases, vol.9, issue.1, pp.57-66, 2009.
DOI : 10.1016/S1473-3099(08)70305-0

S. Fazel, P. Bains, and H. Doll, Substance abuse and dependence in prisoners: a systematic review, Addiction, vol.316, issue.2, pp.181-191, 2006.
DOI : 10.1111/j.1360-0443.2006.01316.x

B. Falissard, J. Loze, I. Gasquet, A. Duburc, C. De-beaurepaire et al., Prevalence of mental disorders in French prisons for men, BMC Psychiatry, vol.162, issue.20, p.33, 2006.
DOI : 10.1016/j.amp.2004.07.002
URL : https://hal.archives-ouvertes.fr/inserm-00097911

S. Fazel and J. Danesh, Serious mental disorder in 23???000 prisoners: a systematic review of 62 surveys, The Lancet, vol.359, issue.9306, pp.545-550, 2002.
DOI : 10.1016/S0140-6736(02)07740-1

A. Knapp, A retro disease on the loose Rise of hepatitis C in prisons may fuel outbreak in general population, Mod Healthc, vol.35, issue.17, p.34, 2005.

O. Timbart and . Les-condamnations-en, Secrétariat Général, Service support et moyens du ministère, Sous-direction de la Statistique et des Études Paris: Ministère de la Justice, 2008.

. Ministry, /. Health, and . Justice, Guide méthodologique relatif à la prise en charge sanitaire des personnes détenues. Paris, 2004.

. Ministry, /. Health, and . Justice, Circulaire n°739 Measures to fight against AIDS in prison setting, 1996.

L. Michel, M. Carrieri, and A. Wodak, Harm reduction and equity of access to care for French prisoners: a review, Harm Reduction Journal, vol.5, issue.1, p.17, 2008.
DOI : 10.1186/1477-7517-5-17

M. Carrieri, D. Rey, and L. Michel, UNIVERSAL HEPATITIS B VIRUS VACCINATION IN FRENCH PRISONS: BREAKING DOWN THE LAST BARRIERS, Addiction, vol.172, issue.7, pp.1311-1312, 2010.
DOI : 10.1111/j.1360-0443.2010.02968.x

M. Backmund, K. Meyer, C. Schuetz, and J. Reimer, Factors associated with exposure to hepatitis B virus in injection drug users, Drug and Alcohol Dependence, vol.84, issue.2, pp.154-159, 2006.
DOI : 10.1016/j.drugalcdep.2006.01.009

W. Small, S. Kain, N. Laliberte, M. Schechter, O. Shaughnessy et al., Incarceration, Addiction and Harm Reduction: Inmates Experience Injecting Drugs in Prison, Substance Use & Misuse, vol.17, issue.6, pp.40831-843, 2005.
DOI : 10.1081/JA-200030795

C. Correctional-service, Evaluation of HIV/AIDS Harm Reduction Measures in the Correctional Service of Canada, 1999.

K. Dolan, J. Shearer, W. Hall, and A. Wodak, Bleach is easier to obtain but inmates are still at risk of infection in New South Wales prisons, 1996.

K. Dolan, A. Wodak, and W. Hall, HIV risk behaviour and prevention in prison: a bleach programme for inmates in NSW, Drug and Alcohol Review, vol.18, issue.2, pp.139-143, 1999.
DOI : 10.1080/09595239996563

M. Macdonald, A Study of health care provision, existing drug services and strategies operating in prisons in ten countries from Central and Eastern Europe. Helsinki: The European Institute for Crime Prevention and Control. HEUNI, 2005.

K. Dolan, Prison research, Addiction, vol.104, issue.2, p.223, 2009.

M. Jauffret-roustide, L. Strat, Y. Couturier, E. Thierry, D. Rondy et al., A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design, BMC Infectious Diseases, vol.102, issue.Suppl 3, p.113, 2009.
DOI : 10.1111/j.1360-0443.2007.01912.x
URL : https://hal.archives-ouvertes.fr/inserm-00663624

G. Greenwald, Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies, SSRN Electronic Journal, 2009.
DOI : 10.2139/ssrn.1543991

. Michel, Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy, BMC Public Health, vol.9, issue.1, p.400, 2011.
DOI : 10.1186/1471-2334-9-113
URL : https://hal.archives-ouvertes.fr/inserm-00605495